AMD’s leadership reaffirmed an ambitious outlook at its recent investor day, forecasting a 60% compound annual growth rate (CAGR) in its data center segment through 2030, driving overall revenue growth of roughly 35% CAGR over the same period. Based on these projections, analysts calculate a potential increase in the company’s equity value of approximately 348% by 2030, which would imply a near fourfold gain for long-term shareholders. While current consensus valuations assume much of this expansion is already priced in—with forward earnings multiple at roughly 33 times—management highlighted opportunities for margin improvement in both processor and accelerator businesses that could deliver upside beyond baseline forecasts.

In the latest regulatory filings for the third quarter, Harel Insurance Investments & Financial Services reduced its stake in AMD by 2.9%, selling 4,050 shares and ending the period with 134,202 shares valued at $21.7 million. At the same time, several smaller institutions boosted their positions: ORG Wealth Partners increased holdings by 39.7% to 162 shares, Pinney & Scofield lifted its stake by 81.0% to 190 shares, Dogwood Wealth Management expanded by 2,311.1% to 217 shares, Avion Wealth grew by 49.3% to 218 shares, and West Branch Capital jumped 3,057.1% to 221 shares. Collectively, institutional investors and hedge funds now control more than 71% of the company’s outstanding shares, underscoring continued confidence among professional allocators despite recent profit-taking by larger holders.

In its most recent quarterly report, AMD delivered revenue of $9.25 billion, exceeding the $8.76 billion consensus by 5.6%, and generated earnings per share of $1.20, beating analyst estimates by $0.03. Revenue climbed 35.6% year-over-year, driven by strength in both enterprise processors and graphics accelerators, while the company posted a net margin of 10.32% and a return on equity of 8.04%. Free cash flow remained strong, and the balance sheet showed a debt-to-equity ratio of just 0.04, with liquidity metrics—a quick ratio of 1.68 and a current ratio of 2.31—indicating ample capacity to fund R&D and manufacturing partnerships in the years ahead.